Glenmark Pharmaceuticals Ltd (GLENMARK)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

65,075.51

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 15,556 full-time employees. The firm is focused on building a global formulation business with branded, generics and over the counter (OTC) segments in the therapy areas of dermatology, respiratory and oncology. The firm also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Its product portfolio includes topical products, liquids, respiratory MDI/DPI, complex injectables and biologics, and oral solids. The firm has a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand, Tiogiva in the United Kingdom and Tavulus in Spain, for the treatment of chronic obstructive pulmonary disease. Ryaltris, the Company's first branded specialty product globally, is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 2,198.5

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

45.56

52-week high

2,537.6

52-week low

1,792.6

Revenue CAGR, 3 years (%)

9.34

Revenue CAGR, 5 years (%)

9.19

EPS CAGR, 3 years (%)

66.11

EPS CAGR, 5 years (%)

7.02

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

46.65%

FII

20.34%

DII

19.29%

Public

13.68%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• Alkem Laboratories Ltd₹ 64,553.14 Cr
• Biocon Ltd₹ 69,262 Cr
• Gland Pharma Ltd₹ 46,509.56 Cr
• IPCA Laboratories Ltd₹ 45,531.03 Cr
• GlaxoSmithKline Pharmaceuticals Ltd₹ 45,206 Cr
• Laurus Labs Ltd₹ 86,501.22 Cr

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

• concall2026-08-05
• quarterly_result2026-07-31
• concall2026-02-04
• quarterly_result2026-01-30
• concall2025-11-19

Source: nse · as of 2026-10-05

Frequently asked questions

What does Glenmark Pharmaceuticals Ltd do?

Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture and marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 15,556 full-time employees. The firm is focused on building a global formulation business with branded, generics and over the counter (OTC) segments in the therapy areas of dermatology, respiratory and oncology. The firm also has a regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Its product portfolio includes topical products, liquids, respiratory MDI/DPI, complex injectables and biologics, and oral solids. The firm has a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand, Tiogiva in the United Kingdom and Tavulus in Spain, for the treatment of chronic obstructive pulmonary disease. Ryaltris, the Company's first branded specialty product globally, is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis.

Which sector is Glenmark Pharmaceuticals Ltd in?

Glenmark Pharmaceuticals Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Glenmark Pharmaceuticals Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 16982.51 Cr, profit after tax 0.10 Cr.

What is the promoter holding and pledge in Glenmark Pharmaceuticals Ltd?

Promoter holding is 46.65%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Glenmark Pharmaceuticals Ltd?

Companies in the same sector of similar size: Alkem Laboratories Ltd, Biocon Ltd, Gland Pharma Ltd, IPCA Laboratories Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Laurus Labs Ltd.